Stifel Financial
AMRX icon

Stifel Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Stifel Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.7M Buy
213,597
+17,860
+9% +$245K ﹤0.01% 1609
2026
Q1 		$2.43M Buy
195,737
+7,405
+4% +$99.4K ﹤0.01% 1820
2025
Q4 		$2.37M Sell
188,332
-1,852
-1% -$21.2K ﹤0.01% 1815
2025
Q3 		$1.9M Buy
190,184
+778
+0.4% +$6.98K ﹤0.01% 1955
2025
Q2 		$1.53M Sell
189,406
-498
-0.3% -$3.75K ﹤0.01% 2035
2025
Q1 		$1.59M Buy
189,904
+1,465
+0.8% +$12.2K ﹤0.01% 1921
2024
Q4 		$1.49M Buy
188,439
+337
+0.2% +$2.83K ﹤0.01% 1983
2024
Q3 		$1.57M Sell
188,102
-378
-0.2% -$2.96K ﹤0.01% 1935
2024
Q2 		$1.2M Buy
188,480
+379
+0.2% +$2.41K ﹤0.01% 2050
2024
Q1 		$1.14M Buy
188,101
+3,336
+2% +$18.8K ﹤0.01% 2104
2023
Q4 		$1.12M Sell
184,765
-915
-0.5% -$4.08K ﹤0.01% 2077
2023
Q3 		$784K Buy
185,680
+39,204
+27% +$146K ﹤0.01% 2212
2023
Q2 		$454K Buy
146,476
+462
+0.3% +$984 ﹤0.01% 2577
2023
Q1 		$203K Buy
146,014
+5,800
+4% +$11.5K ﹤0.01% 3044
2022
Q4 		$279K Buy
140,214
+246
+0.2% +$551 ﹤0.01% 2803
2022
Q3 		$283K Buy
139,968
+11,254
+9% +$31.5K ﹤0.01% 2752
2022
Q2 		$409K Buy
128,714
+3,391
+3% +$12.3K ﹤0.01% 2580
2022
Q1 		$523K Buy
125,323
+37,543
+43% +$166K ﹤0.01% 2550
2021
Q4 		$420K Buy
87,780
+67,917
+342% +$339K ﹤0.01% 2696
2021
Q3 		$106K Buy
+19,863
New +$100K ﹤0.01% 3237
2019
Q2 		– Sell
-587,615
Closed -$8.3M – 2960
2019
Q1 		$8.3M Buy
587,615
+8,648
+1% +$114K 0.02% 606
2018
Q4 		$7.81M Buy
578,967
+134,910
+30% +$2.43M 0.03% 568
2018
Q3 		$9.91M Sell
444,057
-173,438
-28% -$3.65M 0.03% 549
2018
Q2 		$10.1M Buy
+617,495
New +$10.8M 0.03% 534

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Stifel Financial's AMRX Position: Q2 2026 in Review

Stifel Financial increased its Amneal Pharmaceuticals (AMRX) stake by 9.1% in Q2 2026, buying an estimated $245K and bringing the position to 213,597 shares worth $3.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

Stifel Financial first reported a position in AMRX in Q2 2018 and has held it in 24 quarters since. The position peaked at $10.1M in Q2 2018. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Stifel Financial held 213,597 shares of Amneal Pharmaceuticals worth $3.7M as of Q2 2026.
  • Stifel Financial bought 17,860 Amneal Pharmaceuticals shares in Q2 2026, an estimated $245K.
  • Amneal Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #1609 holding.
  • Stifel Financial first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 24 quarters since.
  • Stifel Financial's Amneal Pharmaceuticals position peaked at $10.1M in Q2 2018.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.